{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:28:44Z","timestamp":1793766524208,"version":"4.6.1"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.anndiagpath.2021.151787","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T04:22:33Z","timestamp":1625199753000},"page":"151787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Biomarkers of laryngeal squamous cell carcinoma: a review"],"prefix":"10.1016","volume":"54","author":[{"given":"Matteo","family":"Cavaliere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"D'Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Colacurcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Ralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Cassandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cassandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1916-0216-43-4","article-title":"Management of locally advanced laryngeal cancer","volume":"43","author":"Karatzanis","year":"2014","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151787_bb0010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaoto.2014.1671","article-title":"Survival outcomes in advanced laryngeal cancer","volume":"140","author":"Megwalu","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0015","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0020","first-page":"31","article-title":"An update on larynx cancer","volume":"67","author":"Steuer","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hed.25172","article-title":"Prognosis of subglottic carcinoma: is it really worse?","volume":"41","author":"Coskun","year":"2019","journal-title":"Head Neck"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151787_bb0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ctrv.2006.07.002","article-title":"Current opinion in diagnosis and treatment of laryngeal carcinoma","volume":"32","author":"Marioni","year":"2006","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151787_bb0035","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/lary.27592","article-title":"Supraglottic squamous cell carcinoma: a population-based study of 22,675 cases","volume":"129","author":"Patel","year":"2019","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0194599815618190","article-title":"Subglottic squamous cell carcinoma: a population-based study of 889 cases","volume":"154","author":"Marchiano","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-2004-826075","article-title":"Die Halslymphknotenmetastasierung des glottischen Larynxkarzinoms [Lymph node metastasis of glottic laryngeal carcinoma]","volume":"84","author":"Waldfahrer","year":"2005","journal-title":"Laryngorhinootologie"},{"issue":"14","key":"10.1016\/j.anndiagpath.2021.151787_bb0050","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.3390\/ijms20143444","article-title":"Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours","volume":"20","author":"Cossu","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7150\/jca.5112","article-title":"The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas","volume":"4","author":"Koontongkaew","year":"2013","journal-title":"J Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0060","first-page":"1286","article-title":"Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers","volume":"7","author":"Yang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0065","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00405-011-1831-4","article-title":"Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review","volume":"269","author":"Rodrigo","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","article-title":"lincRNAs: genomics, evolution, and mechanisms","volume":"154","author":"Ulitsky","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding RNA networks in cancer","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fendo.2017.00090","article-title":"The more the merrier-complexity in long non-coding RNA loci","volume":"8","author":"Ziegler","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ncrna.2018.03.001","article-title":"Exploring the mechanisms behind long noncoding RNAs and cancer","volume":"3","author":"Balas","year":"2018","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-018-0823-z","article-title":"The decade of exosomal long RNA species: an emerging cancer antagonist","volume":"17","author":"Zhou","year":"2018","journal-title":"Mol Cancer"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151787_bb0095","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00405-014-3117-0","article-title":"The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma","volume":"272","author":"Gioacchini","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151787_bb0100","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdh299","article-title":"Prognostic relevance of cell proliferation in head and neck tumors","volume":"15","author":"Pich","year":"2004","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0385-8146(99)00005-X","article-title":"Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia","volume":"26","author":"Izawa","year":"1999","journal-title":"Auris Nasus Larynx"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0110","first-page":"1459","article-title":"Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma","volume":"29","author":"Cordes","year":"2009","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0115","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00405-013-2833-1","article-title":"p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival","volume":"271","author":"Re","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hed.10218","article-title":"Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations","volume":"25","author":"Liu","year":"2003","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1368-8375(98)00100-6","article-title":"Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions","volume":"35","author":"Krecicki","year":"1999","journal-title":"Oral Oncol"},{"issue":"1A","key":"10.1016\/j.anndiagpath.2021.151787_bb0130","first-page":"335","article-title":"Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer","volume":"27","author":"Pastuszewski","year":"2007","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0135","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/00016480500416785","article-title":"Is Ki67 a marker for the transformation of laryngeal dysplasia to carcinoma?","volume":"126","author":"Mirza","year":"2006","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1053\/ajot.2003.17","article-title":"Retrospective analysis of Ki-67 antigen expression in paraffin tissue blocks of laryngeal squamous cell carcinoma","volume":"24","author":"Fumic-Dunkic","year":"2003","journal-title":"Am J Otolaryngol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151787_bb0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00405-003-0651-6","article-title":"p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma","volume":"260","author":"Mielcarek-Kuchta","year":"2003","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151787_bb0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00405-003-0699-3","article-title":"Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy","volume":"261","author":"Acikalin","year":"2004","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0155","first-page":"219","article-title":"The role of p53, PCNA and Ki-67 as outcome predictors in the treatment of laryngeal cancer","volume":"2","author":"Sarafoleanu","year":"2009","journal-title":"J Med Life"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0160","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00005537-200006000-00024","article-title":"Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma","volume":"110","author":"Sittel","year":"2000","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151787_bb0165","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/00005537-199810000-00023","article-title":"Ki-67 and p53 in T2 laryngeal cancer","volume":"108","author":"Kropveld","year":"1998","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.anl.2007.08.011","article-title":"Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy","volume":"35","author":"Ahmed","year":"2008","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0360-3016(00)00409-0","article-title":"Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index","volume":"47","author":"Sakata","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0180","first-page":"124","article-title":"Ki-67 expression predicts radiotherapy failure in early glottic cancer","volume":"41","author":"Nichols","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"11 Pt 1","key":"10.1016\/j.anndiagpath.2021.151787_bb0185","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/00005537-200111000-00002","article-title":"P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy","volume":"111","author":"Lavertu","year":"2001","journal-title":"Laryngoscope"},{"issue":"6456","key":"10.1016\/j.anndiagpath.2021.151787_bb0190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0195","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00405-014-3426-3","article-title":"The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma","volume":"273","author":"Gioacchini","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151787_bb0200","first-page":"10340","article-title":"Biomarkers of head and neck cancer, tools or a gordian knot?","volume":"8","author":"Lampri","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/lary.24245","article-title":"Biomarkers in advanced larynx cancer","volume":"124","author":"Bradford","year":"2014","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151787_bb0210","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3892\/ol.2015.3726","article-title":"p27Kip1 expression as a prognostic marker for squamous cell carcinoma of the head and neck","volume":"10","author":"De Almeida","year":"2015","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jcp.22723","article-title":"Alteration of G1\/S transition regulators influences recurrences in head and neck squamous carcinomas","volume":"227","author":"Canzonieri","year":"2012","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0220","first-page":"75","article-title":"Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review","volume":"25","author":"Pignataro","year":"2005","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0225","first-page":"5","article-title":"Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control","volume":"58","author":"Andl","year":"1998","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hed.10335","article-title":"The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil","volume":"26","author":"Li","year":"2004","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12105-010-0166-6","article-title":"Integration of biomarkers including molecular targeted therapies in head and neck cancer","volume":"4","author":"Williams","year":"2010","journal-title":"Head Neck Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0240","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/lio2.353","article-title":"Prognostic factors in laryngeal squamous cell carcinoma","volume":"5","author":"Bradford","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0245","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/bjc.2015.59","article-title":"Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma","volume":"112","author":"Young","year":"2015","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151787_bb0250","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/lary.20509","article-title":"Human papillomavirus in early laryngeal carcinoma","volume":"119","author":"Baumann","year":"2009","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0255","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2007.05.003","article-title":"PCNA, the maestro of the replication fork","volume":"129","author":"Moldovan","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ijc.2910560117","article-title":"Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions","volume":"56","author":"Munck-Wikland","year":"1994","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0196-0709(96)90041-1","article-title":"Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx","volume":"17","author":"Zhao","year":"1996","journal-title":"Am J Otolaryngol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0270","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.5301\/jbm.5000116","article-title":"Prognostic value of Bcl-2 expression in squamous cell carcinoma of the larynx: a systematic review","volume":"30","author":"Gioacchini","year":"2015","journal-title":"Int J Biol Markers"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0275","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjoto.2010.01.012","article-title":"Alterations of p53 and Bcl-2 protein expression in the recurrent laryngeal and pharyngeal squamous cell carcinoma","volume":"32","author":"Rashad","year":"2011","journal-title":"Am J Otolaryngol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0280","doi-asserted-by":"crossref","first-page":"239","DOI":"10.18632\/oncotarget.134","article-title":"The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens","volume":"1","author":"Straten","year":"2010","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151787_bb0285","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00005537-199805000-00002","article-title":"Regulators of proliferation and apoptosis in carcinoma of the larynx","volume":"108","author":"Whisler","year":"1998","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0959-8049(98)00347-5","article-title":"Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression","volume":"35","author":"Hirvikoski","year":"1999","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0295","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hed.1031","article-title":"Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma","volume":"23","author":"Friedman","year":"2001","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151787_bb0300","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s004050100383","article-title":"Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma","volume":"258","author":"Klatka","year":"2001","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0305","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/147323000203000608","article-title":"Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma","volume":"30","author":"Yildirim","year":"2002","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.otohns.2004.02.015","article-title":"c-Myc and bcl-2 expression in supraglottic squamous cell carcinoma of the larynx","volume":"131","author":"Ozdek","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0315","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1097-0215(19980619)79:3<263::AID-IJC9>3.0.CO;2-N","article-title":"Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous cell carcinoma","volume":"79","author":"Pruneri","year":"1998","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0320","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000093055","article-title":"Expression of the antiapoptotic proteins clusterin and bcl-2 in laryngeal squamous cell carcinomas","volume":"27","author":"Redondo","year":"2006","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0325","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2273.2001.00441.x","article-title":"The clinicopathological significance of bcl-2 expression in the surgical treatment of laryngeal carcinoma","volume":"26","author":"Yuen","year":"2001","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"12","key":"10.1016\/j.anndiagpath.2021.151787_bb0330","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/sj.bjc.6602647","article-title":"Bcl-2 expression predicts radiotherapy failure in laryngeal cancer","volume":"92","author":"Nix","year":"2005","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jop.12020","article-title":"Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study","volume":"42","author":"Marioni","year":"2013","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0340","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<591::AID-CNCR9>3.0.CO;2-F","article-title":"Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression","volume":"85","author":"J\u00e4ckel","year":"1999","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.anndiagpath.2021.151787_bb0345","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.onc.1210280","article-title":"p53 alterations in human cancer: more questions than answers","volume":"26","author":"Soussi","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2018.07.008","article-title":"The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma","volume":"55","author":"Chan","year":"2019","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0355","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0360","first-page":"171","article-title":"Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods","volume":"8","author":"Lu","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0370","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00000421-200212000-00012","article-title":"Predictive value of P53, BCL-2, and BAX in advanced head and neck carcinoma","volume":"25","author":"Casado","year":"2002","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hed.10339","article-title":"Prognostic significance of p53 expression in oral squamous cell carcinoma without neck noted metastases","volume":"26","author":"de Vicente","year":"2004","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0380","first-page":"277","article-title":"Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features","volume":"23","author":"Ioachim","year":"2004","journal-title":"J Exp Clin Res"},{"issue":"25","key":"10.1016\/j.anndiagpath.2021.151787_bb0385","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa073770","article-title":"TP53 mutations and survival in squamous-cell carcinoma of the head and neck","volume":"357","author":"Poeta","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0390","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/1055-9965.EPI-09-0981","article-title":"A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck","volume":"19","author":"Tandon","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151787_bb0395","first-page":"2199","article-title":"Immunohistochemical staining for markers of future neoplastic progression in the larynx","volume":"56","author":"Uhlman","year":"1996","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151787_bb0400","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1034\/j.1600-0714.2000.290901.x","article-title":"The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck","volume":"29","author":"Nylander","year":"2000","journal-title":"J Oral Pathol Med"},{"issue":"11","key":"10.1016\/j.anndiagpath.2021.151787_bb0405","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm.3388","article-title":"The quest to overcome resistance to EGFR-targeted therapies in cancer","volume":"19","author":"Chong","year":"2013","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.anndiagpath.2021.151787_bb0410","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","article-title":"The epidermal growth factor receptor pathway: a model for targeted therapy","volume":"12","author":"Scaltriti","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"26","key":"10.1016\/j.anndiagpath.2021.151787_bb0415","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2007.11.8497","article-title":"Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy","volume":"25","author":"Riesterer","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0420","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/00016489.2011.652308","article-title":"Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma","volume":"132","author":"Lionello","year":"2012","journal-title":"Acta Otolaryngol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151787_bb0425","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/00016489.2019.1651938","article-title":"Association between EGFR expression and clinical outcome of laryngeal HPV squamous cell carcinoma","volume":"139","author":"Konti\u0107","year":"2019","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0430","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<188::AID-IJC16>3.0.CO;2-1","article-title":"Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse","volume":"84","author":"Almadori","year":"1999","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0435","first-page":"259","article-title":"Correlation between the expression of HER-2\/neu, nm23 protein and local invasion and lymph node metastasis of human LSCC","volume":"20","author":"Li","year":"2006","journal-title":"J Clin Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0440","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.oraloncology.2004.09.011","article-title":"Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer","volume":"41","author":"Pivot","year":"2005","journal-title":"Oral Oncol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0445","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jcp.54.3.201","article-title":"Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis","volume":"54","author":"Franchi","year":"2001","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0450","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.amjoto.2007.08.003","article-title":"Transforming growth factor beta isoforms [TGF-beta1, TGF-beta2, TGF-beta3] messenger RNA expression in laryngeal cancer","volume":"29","author":"Kapral","year":"2008","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0455","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/135285","article-title":"Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis","volume":"2010","author":"Mosch","year":"2010","journal-title":"J Oncol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151787_bb0460","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/00016480601089382","article-title":"Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients\u2019 prognosis","volume":"127","author":"Shigyo","year":"2007","journal-title":"Acta Otolaryngol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2021.151787_bb0465","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00405-005-0916-3","article-title":"Clinical and molecular prognostic factors in operable laryngeal cancer","volume":"262","author":"Vlachtsis","year":"2005","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0470","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hed.21551","article-title":"Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 tumor expression in patients with advanced laryngeal cancer after induction chemotherapy for organ preservation","volume":"33","author":"Rueda","year":"2011","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0475","first-page":"105","article-title":"Larenksin skuam\u00f6z h\u00fccreli kanserlerinde vask\u00fcler endotelyal b\u00fcy\u00fcme fakt\u00f6r\u00fcn\u00fcn anjiyogenez ve p53 geni ile ili\u015fkisi [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma]","volume":"16","author":"Yaylaci","year":"2006","journal-title":"Kulak Burun Bogaz Ihtis Derg"},{"issue":"1B","key":"10.1016\/j.anndiagpath.2021.151787_bb0480","first-page":"551","article-title":"Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1\/Kdr) expression","volume":"28","author":"Marioni","year":"2008","journal-title":"Anticancer Res"},{"issue":"4\u20135","key":"10.1016\/j.anndiagpath.2021.151787_bb0485","first-page":"176","article-title":"Histologic correlation of VEGF and COX-2 expression with tumor size in squamous cell carcinoma of the larynx and hypopharynx","volume":"96","author":"Bonhin","year":"2017","journal-title":"Ear Nose Throat J"},{"issue":"39","key":"10.1016\/j.anndiagpath.2021.151787_bb0490","doi-asserted-by":"crossref","first-page":"14519","DOI":"10.1073\/pnas.0606708103","article-title":"A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation","volume":"103","author":"Yoshioka","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0495","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2010.03664.x","article-title":"Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival","volume":"57","author":"Marioni","year":"2010","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0500","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcms.2003.11.004","article-title":"Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?","volume":"32","author":"Schimming","year":"2004","journal-title":"J Craniomaxillofac Surg"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151787_bb0505","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ejso.2006.08.001","article-title":"CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma","volume":"32","author":"Marioni","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2021.151787_bb0510","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00405-009-0962-3","article-title":"CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma","volume":"266","author":"Zvrko","year":"2009","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0515","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.anl.2009.05.005","article-title":"Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma","volume":"37","author":"Zvrko","year":"2010","journal-title":"Auris Nasus Larynx"},{"issue":"12","key":"10.1016\/j.anndiagpath.2021.151787_bb0520","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00405-011-1743-3","article-title":"Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression","volume":"268","author":"Marioni","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0525","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.anl.2011.04.003","article-title":"Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma","volume":"39","author":"Li","year":"2012","journal-title":"Auris Nasus Larynx"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151787_bb0530","doi-asserted-by":"crossref","first-page":"504","DOI":"10.14639\/0392-100X-2106","article-title":"The prognostic significance of E-cadherin expression in laryngeal squamous-cell carcinoma: a systematic review","volume":"38","author":"Re","year":"2018","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151787_bb0535","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2168.2000.01513.x","article-title":"E-cadherin-catenin cell-cell adhesion complex and human cancer","volume":"87","author":"Wijnhoven","year":"2000","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151787_bb0540","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.7314\/APJCP.2013.14.9.5301","article-title":"Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin","volume":"14","author":"Akdeniz","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0545","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12253-014-9741-6","article-title":"Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma","volume":"20","author":"Ahmed","year":"2014","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0550","first-page":"761","article-title":"E-cadherin, \u03b2-catenin and Snail immunoexpression in laryngeal squamous cell carcinoma","volume":"58","author":"Cercelaru","year":"2017","journal-title":"Rom J Morphol Embryol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0555","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archotol.133.2.145","article-title":"Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer","volume":"133","author":"Rodrigo","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0560","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CEJ.0b013e32832f9aa6","article-title":"Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma","volume":"19","author":"Zou","year":"2010","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0565","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/his.12668","article-title":"The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and slug in laryngeal squamous cell carcinoma","volume":"67","author":"Cappellesso","year":"2015","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.anndiagpath.2021.151787_bb0570","first-page":"5245","article-title":"Expression of E-cadherin and \u03b1-catenin in T1 N0 laryngeal cancer","volume":"32","author":"Carico","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0575","article-title":"Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0580","first-page":"379","article-title":"Role of CD44 as a marker of cancer stem cells in head and neck cancer","volume":"6","author":"Trapasso","year":"2012","journal-title":"Biologics"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0585","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hed.21699","article-title":"Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness","volume":"34","author":"Joshua","year":"2012","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151787_bb0590","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/hed.21420","article-title":"Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neck","volume":"33","author":"Chikamatsu","year":"2011","journal-title":"Head Neck"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151787_bb0595","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ejca.2010.02.024","article-title":"CD44, a therapeutic target for metastasising tumours","volume":"46","author":"Orian-Rousseau","year":"2010","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151787_bb0600","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.10421","article-title":"Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints","volume":"46","author":"Wibulswas","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0605","first-page":"1113","article-title":"Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA","volume":"14","author":"Ioachim","year":"1999","journal-title":"Histol Histopathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151787_bb0610","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1647","article-title":"The role of focal-adhesion kinase in cancer \u2013 a new therapeutic opportunity","volume":"5","author":"McLean","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151787_bb0615","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1158\/1940-6207.CAPR-10-0338","article-title":"Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy","volume":"4","author":"Rodrigo","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151787_bb0620","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/1055-9965.EPI-17-1082","article-title":"Immunohistochemical expression of cortactin and focal adhesion kinase predicts recurrence risk and laryngeal cancer risk beyond histologic grading","volume":"27","author":"Villaronga","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0625","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5301\/ijbm.5000297","article-title":"Cortactin and phosphorylated cortactin Tyr421 and Tyr466 expression in Supraglottic laryngeal carcinomas and lymph node metastases","volume":"33","author":"Marioni","year":"2018","journal-title":"Int J Biol Markers"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151787_bb0630","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/sj.bjc.6604246","article-title":"Cortactin expression predicts poor survival in laryngeal carcinoma","volume":"98","author":"Gibcus","year":"2008","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151787_bb0635","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/path.2462","article-title":"Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas","volume":"217","author":"Rodrigo","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0640","first-page":"152","article-title":"Estrogen signaling and estrogen receptors as prognostic indicators in laryngeal cancer","volume":"108498","author":"Verma","year":"2019","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151787_bb0645","first-page":"1063","article-title":"Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers","volume":"22","author":"Goulioumis","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0650","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.steroids.2017.11.012","article-title":"Estradiol receptor profile and estrogen responsiveness in laryngeal cancer and clinical outcomes","volume":"142","author":"Schwartz","year":"2019","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151787_bb0655","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/00016489.2017.1373851","article-title":"Sex-related hormone receptor in laryngeal squamous cell carcinoma: correlation with androgen estrogen-\u0251 and prolactin receptor expression and influence of prognosis","volume":"138","author":"Fei","year":"2018","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0660","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tice.2019.02.007","article-title":"The prognostic value of sex hormone receptors expression in laryngeal carcinoma","volume":"57","author":"Atef","year":"2019","journal-title":"Tissue Cell"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151787_bb0665","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151787_bb0670","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/annonc\/mdw226","article-title":"The promise of immunotherapy in head and neck squamous cell carcinoma","volume":"27","author":"Economopoulou","year":"2016","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151787_bb0675","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1341030","article-title":"Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV\/p16 in head and neck cancer treated with bio- or chemo-radiotherapy","volume":"6","author":"Ou","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0680","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/1078-0432.CCR-15-1543","article-title":"Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma","volume":"22","author":"Vassilakopoulou","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0685","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.2147\/OTT.S113307","article-title":"The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma","volume":"9","author":"Wang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0690","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fonc.2019.00827","article-title":"Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting","volume":"9","author":"Economopoulou","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151787_bb0695","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.anndiagpath.2021.151787_bb0700","doi-asserted-by":"crossref","first-page":"e731","DOI":"10.1016\/S1470-2045(17)30607-1","article-title":"De-novo and acquired resistance to immune checkpoint targeting","volume":"18","author":"Syn","year":"2017","journal-title":"Lancet Oncol"},{"issue":"Pt 2","key":"10.1016\/j.anndiagpath.2021.151787_bb0705","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151787_bb0710","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.oraloncology.2014.11.014","article-title":"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma","volume":"51","author":"Ritprajak","year":"2015","journal-title":"Oral Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:56Z","timestamp":1761078776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":142,"alternative-id":["S1092913421000873"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151787","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of laryngeal squamous cell carcinoma: a review","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151787"}}